Katsuhito Mori

7.9k total citations · 1 hit paper
172 papers, 5.9k citations indexed

About

Katsuhito Mori is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katsuhito Mori has authored 172 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Nephrology, 42 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katsuhito Mori's work include Parathyroid Disorders and Treatments (37 papers), Dialysis and Renal Disease Management (27 papers) and Chronic Kidney Disease and Diabetes (18 papers). Katsuhito Mori is often cited by papers focused on Parathyroid Disorders and Treatments (37 papers), Dialysis and Renal Disease Management (27 papers) and Chronic Kidney Disease and Diabetes (18 papers). Katsuhito Mori collaborates with scholars based in Japan, United States and Venezuela. Katsuhito Mori's co-authors include Yoshiki Nishizawà, Atsushi Shioi, Masanori Emoto, Shuichi Jono, Masaaki Inaba, Tetsuo Shoji, Hirotoshi Morii, Hidenori Koyama, Marc D. McKee and Charles E. Murry and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Katsuhito Mori

161 papers receiving 5.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphate Regulation of Vascular Smooth Muscle Cell Calcification

2000 1.1k citations Shuichi Jono, Atsushi Shioi et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katsuhito Mori Japan	36	2.4k	1.2k	1.1k	863	808	172	5.9k
Eiji Ishimura Japan	44	3.1k 1.3×	786 0.6×	1.7k 1.6×	1.5k 1.7×	1.1k 1.3×	180	6.9k
Dieter Haffner Germany	44	3.2k 1.3×	1.5k 1.2×	845 0.8×	365 0.4×	789 1.0×	247	6.5k
Hideki Hirakata Japan	43	2.7k 1.1×	660 0.5×	541 0.5×	645 0.7×	648 0.8×	161	5.8k
Masanori Emoto Japan	52	2.1k 0.9×	1.0k 0.8×	2.3k 2.2×	2.9k 3.4×	1.4k 1.7×	258	8.7k
Daniela Corna Italy	46	2.3k 1.0×	2.1k 1.7×	710 0.7×	1.3k 1.6×	1.3k 1.6×	105	6.7k
Hirotoshi Morii Japan	37	2.2k 0.9×	1.3k 1.0×	919 0.9×	856 1.0×	847 1.0×	169	5.8k
Joon-Keun Park Germany	45	881 0.4×	1.8k 1.4×	1.3k 1.2×	1.9k 2.2×	1.8k 2.3×	74	7.1k
Nobukazu Ishizaka Japan	42	1.1k 0.5×	2.5k 2.0×	730 0.7×	1.9k 2.2×	1.4k 1.7×	200	7.4k
Hideki Tahara Japan	28	1.1k 0.5×	466 0.4×	1.0k 1.0×	767 0.9×	530 0.7×	75	3.3k
Duska Dragun Germany	51	2.2k 0.9×	1.5k 1.2×	588 0.6×	1.3k 1.6×	2.5k 3.1×	167	8.7k

Countries citing papers authored by Katsuhito Mori

Since Specialization

Citations

This map shows the geographic impact of Katsuhito Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhito Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhito Mori more than expected).

Fields of papers citing papers by Katsuhito Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuhito Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhito Mori. The network helps show where Katsuhito Mori may publish in the future.

Co-authorship network of co-authors of Katsuhito Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuhito Mori. A scholar is included among the top collaborators of Katsuhito Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuhito Mori. Katsuhito Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakatani, Shinya, Katsuhito Mori, Toshihide Naganuma, et al.. (2024). New-onset Kidney Biopsy-proven Membranous Nephropathy Induced End-stage Kidney Disease in a Living Donor. Internal Medicine. 63(18). 2537–2541.

Uedono, Hideki, Masafumi Kurajoh, Akihiro Tsuda, et al.. (2024). Association Between Plasma Aldosterone Concentration and Intraglomerular Hemodynamics in Primary Aldosteronism. American Journal of Hypertension. 37(10). 801–809. 1 indexed citations

Fukumoto, Shinya, Hideki Uedono, Shinya Nakatani, et al.. (2024). T50 Calciprotein Crystallization and the Decreased Role of Fetuin-A in Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 32(6). 763–774. 3 indexed citations

Mori, Katsuhito, Yosuke Yamamoto, Norio Hanafusa, et al.. (2024). Association of Nutritional Risk Index With Infection-Related Hospitalization and Death After Hospitalization in Patients Undergoing Maintenance Hemodialysis. Journal of Renal Nutrition. 35(1). 187–195.

Nakatani, Shinya, et al.. (2023). Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study. Journal of Clinical Medicine. 12(19). 6341–6341. 14 indexed citations

Morioka, Tomoaki, Yoshinori Kakutani, Yuko Yamazaki, et al.. (2023). Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 30(12). 1838–1848. 1 indexed citations

Nakatani, Shinya, et al.. (2022). Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism. Advances in experimental medicine and biology. 1362. 47–54. 5 indexed citations

Ishimura, Eiji, Senji Okuno, Shinya Nakatani, et al.. (2021). Significant Association of Diabetes With Mortality of Chronic Hemodialysis Patients, Independent of the Presence of Obesity, Sarcopenia, and Sarcopenic Obesity. Journal of Renal Nutrition. 32(1). 94–101. 12 indexed citations

Inaba, Masaaki, Yasuo Imanishi, Noriyuki Hayashi, et al.. (2019). Denosumab Improves Glomerular Filtration Rate in Osteoporotic Patients With Normal Kidney Function by Lowering Serum Phosphorus. Journal of Bone and Mineral Research. 34(11). 2028–2035. 11 indexed citations

10.

Inaba, Masaaki, Katsuhito Mori, Masafumi Kurajoh, et al.. (2018). Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients. Scientific Reports. 8(1). 14699–14699. 7 indexed citations

11.

Mori, Katsuhito. (2017). Potential Advantage of Repaglinide Monotherapy in Glycemic Control in Patients with Type 2 Diabetes and Severe Renal Impairment. Acta Endocrinologica (Bucharest). 13(2). 133–137. 2 indexed citations

12.

Mori, Katsuhito, Chie Nakagawa, Yasuro Kumeda, et al.. (2015). Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring. Journal of Diabetes and its Complications. 29(8). 1310–1313. 23 indexed citations

13.

Imamura, Satoshi, Tomoaki Morioka, Yuko Yamazaki, et al.. (2014). Plasma polyunsaturated fatty acid profile and delta-5 desaturase activity are altered in patients with type 2 diabetes. Metabolism. 63(11). 1432–1438. 22 indexed citations

14.

Nagata, Yuki, Minoru Inaba, Yasuo Imanishi, et al.. (2014). Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporosis International. 26(3). 1053–1061. 27 indexed citations

15.

Mori, Katsuhito, Masanori Emoto, & Masaaki Inaba. (2012). Fetuin-A and the cardiovascular system. Advances in clinical chemistry. 56. 175–195. 66 indexed citations

16.

Jono, Shuichi, S Otsuki, Yasutomi Higashikuni, et al.. (2010). Serum osteoprotegerin levels and long‐term prognosis in subjects with stable coronary artery disease. Journal of Thrombosis and Haemostasis. 8(6). 1170–1175. 35 indexed citations

17.

Mori, Katsuhito & Shuichi Jono. (2007). [Calcified coronary artery disease and serum markers].. PubMed. 17(3). 340–5.

18.

Araki, Takahiro, Masanori Emoto, Megumi Teramura, et al.. (2006). Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin. Metabolism. 55(8). 996–1001. 32 indexed citations

19.

Shioi, Atsushi, Yasuhisa Okuno, Katsuhito Mori, et al.. (2002). Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells. Circulation Research. 91(1). 9–16. 232 indexed citations

20.

Shioi, Atsushi, Katsuhito Mori, Shuichi Jono, et al.. (2000). Mechanism of atherosclerotic calcification. Zeitschrift für Kardiologie. 89(14). S075–S079. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact